Company / Capital Returned to Shareholders
Progyny Capital Returned to Shareholders History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$81.7M
FY2025
5-year range
$0 / $300.3M
FY2021-FY2025
Trend
-72.8%
vs FY2024
Sector context
#58 of 103
Health Care
What the data says
At $82M, Progyny's capital returned to shareholders ranks #58 of 103 in the Health Care sector. Improved from $0 to $82M over the past 2 years.
Based on SEC 10-K filings.
$82M in FY2025.
Improved from $0 to $82M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#58 of 103 in Health CareTop 56% of 103This company $81.7M Sector average $721.8M
▼
-88.7% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders decreased 72.8% year-over-year.
- Ranks #58 out of 103 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2024.
- Lowest capital returned to shareholders in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $81.7M | -72.8% |
| FY2024 | $300.3M | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $185.0K | -84.6% |
| FY2018 | $1.2M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026